White coat effect in patients with hypertension

被引:0
|
作者
Andreeva, G. F. [1 ]
Gorbunov, V. M. [1 ]
Antipushina, D. N. [1 ]
Platonova, E., V [1 ]
机构
[1] Natl Med Res Ctr Therapy & Prevent Med, Moscow, Russia
关键词
hypertension; white coat effect; 24-hour blood pressure monitoring; AMBULATORY BLOOD-PRESSURE; ANTIHYPERTENSIVE TREATMENT; ARTERIAL-HYPERTENSION; PULSE PRESSURE; HOME; DIFFERENCE; OFFICE; DETERMINANTS; REACTIVITY; PREVALENCE;
D O I
10.20996/1819-6446-2023-2926
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The article is devoted to various aspects of white coat effect (WCE) in patients with hypertension (HTN). WCE is due to the patient's anxious response to office blood pressure (BP) measurement and is characterized by a BP increase. In patients with HTN, WCE is detected with a high frequency. Pronounced WCE in hypertensive patients is associated with worsening the HTN course and the prognosis of all-cause and cardiovascular mortality. In addition, BP increase in these patients during a doctor's visit may lead to additional prescription of antihypertensive drugs, increasing costs and side effects. To identify WCE, a large number of methods are used, which can be divided into following groups: I - data from clinical and daytime ambulatory blood pressure measurement, II - clinical and home BP assessment, III - only ambulatory BP measurement, IV - clinical and laboratory BP data, and V - only clinical BP measurement. There are following WCE in patients with HTN: female sex, age, never smoking, as well as anxiety, introversion, etc. WCE is due to the patient's anxiety state during office BP measurement and a conditioned reflex BP increase associated both with the physician presence and medical background. Severe WCE in some groups of patients with HTN may be associated with a worse prognosis compared with other hypertensive patients as follows: in individuals with a significant difference between clinical and ambulatory blood pressure levels or between the first and third BP office data, with a combination of resistant HTN and WCE, with WCE increasing from visit to visit, etc.
引用
收藏
页码:508 / 519
页数:12
相关论文
共 50 条
  • [41] Predictors for the white coat effect in general practice patients with suspected and treated hypertension
    Lindbæk, M
    Sandvik, E
    Liodden, K
    Mjell, J
    Ravnsborg-Gjertsen, K
    BRITISH JOURNAL OF GENERAL PRACTICE, 2003, 53 (495) : 790 - 793
  • [42] Risk of Atrial Fibrillation in Masked and White Coat Uncontrolled Hypertension
    Coccina, Francesca
    Pierdomenico, Anna M.
    de Rosa, Matteo
    Lorenzo, Belli
    Foglietta, Melissa
    Petrilli, Ivan
    Vitulli, Piergiusto
    Pizzicannella, Jacopo
    Trubiani, Oriana
    Cipollone, Francesco
    Renda, Giulia
    Pierdomenico, Sante D.
    AMERICAN JOURNAL OF HYPERTENSION, 2021, 34 (05) : 504 - 510
  • [43] Reduction of white coat effect by cilnidipine in essential hypertension
    Morimoto, S
    Takeda, K
    Oguni, A
    Kido, H
    Harada, S
    Moriguchi, J
    Itoh, H
    Nakata, T
    Sasaki, S
    Nakagawa, M
    AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (10) : 1053 - 1057
  • [44] Should White-Coat Hypertension in Diabetes Be Treated? Pro
    Mancia, Giuseppe
    Sega, Roberto
    Bombelli, Michele
    Quarti-Trevano, Fosca
    Facchetti, Rita
    Grassi, Guido
    DIABETES CARE, 2009, 32 : S305 - S309
  • [45] Talking effect and white coat phenomenon in hypertensive patients
    LePailleur, C
    Vacheron, A
    Landais, P
    MounierVehier, C
    Feder, JM
    Montgermont, P
    Jais, JP
    Metzger, JP
    BEHAVIORAL MEDICINE, 1996, 22 (03) : 114 - 122
  • [46] Prevalence of white coat hypertension in adult primary care attenders
    Chan, Chun Wai
    Hong, Ann Geok
    Jadi, Nor Aszleen binti Md
    Athappan, Sornavally
    Vivekanandan, Pur Maroly
    Poongavanam, Athimoolam
    Lee, Verna Kar Mun
    Lieng, Cheong
    AUSTRALASIAN MEDICAL JOURNAL, 2019, 12 (06): : 169 - 175
  • [47] The differential diagnostic value of serum homocysteine for white coat hypertension
    Guo, Shitian
    Lin, Hui
    Pan, Sunlei
    Zhai, Xiaoya
    Meng, Liping
    ONCOTARGET, 2017, 8 (60) : 101271 - 101283
  • [48] RENAL SODIUM HANDLING IN PATIENTS WITH UNTREATED HYPERTENSION AND WHITE COAT HYPERTENSION
    BURNIER, M
    BIOLLAZ, J
    MAGNIN, JL
    BIDLINGMEYER, M
    BRUNNER, HR
    HYPERTENSION, 1994, 23 (04) : 496 - 502
  • [49] Clinical significance of white-coat hypertension
    Mancia, Giuseppe
    JOURNAL OF HYPERTENSION, 2016, 34 (04) : 623 - 626
  • [50] The Cardiovascular Risk of White-Coat Hypertension
    Franklin, Stanley S.
    Thijs, Lutgarde
    Asayama, Kei
    Li, Yan
    Hansen, Tine W.
    Boggia, Jose
    Jacobs, Lotte
    Zhang, Zhenyu
    Kikuya, Masahiro
    Bjorklund-Bodegard, Kristina
    Ohkubo, Takayoshi
    Yang, Wen-Yi
    Jeppesen, Jorgen
    Dolan, Eamon
    Kuznetsova, Tatiana
    Stolarz-Skrzypek, Katarzyna
    Tikhonoff, Valerie
    Malyutina, Sofia
    Casiglia, Edoardo
    Nikitin, Yuri
    Lind, Lars
    Sandoya, Edgardo
    Kawecka-Jaszcz, Kalina
    Filipovsky, Jan
    Imai, Yutaka
    Wang, Ji-Guang
    O'Brien, Eoin
    Staessen, Jan A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (19) : 2033 - 2043